Drug Markets/Umeclidinium

Umeclidinium

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Umeclidinium is used to treat chronic bronchitis and pulmonary emphysema, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Umeclidinium is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $10.28 to $11.29 per EAa 10% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$10.28 – $11.29

per EA

7d Activity

110 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing UMECLIDINIUM

Drug Portfolio

2 NDCs total, 2 shown

Drug Price 7d Change
INCRUSE ELLIPTA 62.5 MCG INH
$11.2935
per EA
-0.02%
INCRUSE ELLIPTA 62.5 MCG INH
$10.2770
per EA
+0.02%

Frequently Asked Questions

What is Umeclidinium used to treat?

Umeclidinium is used to treat chronic bronchitis and pulmonary emphysema, per the National Library of Medicine's MED-RT classification.

How many Umeclidinium products are on the market?

The Umeclidinium drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Umeclidinium?

NADAC reference prices for Umeclidinium range from $10.2770 to $11.2935 per EA — a 10% difference between cheapest and most expensive.

Which manufacturers make Umeclidinium?

1 manufacturer lists Umeclidinium in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (2).

How has the price of Umeclidinium changed recently?

Over the past 7 days, 1 Umeclidinium NDC rose and 1 fell, with a market-wide average change of +0.0%.